Semaglutide exerts glucose-lowering effects through multiple mechanisms, and understanding how dietary sugar intake influences these effects is important for safe and effective treatment
While this article has focused on the differing requirements for people using GLP-1s for weight loss, the list of proposed indications for GLP-1s grows seemingly on a daily basis, with research currently ongoing in neurodegenerative disease, chronic kidney disease and liver disease
The average weight loss on any of the four medications was 7.9 kg (17.4 lbs), and after ceasing usage, the monthly rate of weight regain was 0.7 kg (1.5 lbs)
It is used for glucose-level management and has shown promising potential for weight-loss management
In contrast, Farxiga can lead to more frequent urination, urinary tract infections, and yeast infections because it helps the body get rid of extra sugar through urine